IBDEI096 ; ; 01-AUG-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;AUG 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,22421,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22421,1,3,0)
;;=3^Waldenstrom Macroglobulinemia
;;^UTILITY(U,$J,358.3,22421,1,4,0)
;;=4^C88.0
;;^UTILITY(U,$J,358.3,22421,2)
;;=^5001748
;;^UTILITY(U,$J,358.3,22422,0)
;;=C91.02^^71^914^3
;;^UTILITY(U,$J,358.3,22422,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22422,1,3,0)
;;=3^Acute Lymphoblastic Leukemia,In Relapse
;;^UTILITY(U,$J,358.3,22422,1,4,0)
;;=4^C91.02
;;^UTILITY(U,$J,358.3,22422,2)
;;=^5001764
;;^UTILITY(U,$J,358.3,22423,0)
;;=C92.02^^71^914^6
;;^UTILITY(U,$J,358.3,22423,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22423,1,3,0)
;;=3^Acute Myeloblastic Leukemia,In Relapse
;;^UTILITY(U,$J,358.3,22423,1,4,0)
;;=4^C92.02
;;^UTILITY(U,$J,358.3,22423,2)
;;=^5001791
;;^UTILITY(U,$J,358.3,22424,0)
;;=D09.3^^71^914^50
;;^UTILITY(U,$J,358.3,22424,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22424,1,3,0)
;;=3^Carcinoma in Situ of Thyroid/Oth Endocrine Glands
;;^UTILITY(U,$J,358.3,22424,1,4,0)
;;=4^D09.3
;;^UTILITY(U,$J,358.3,22424,2)
;;=^5001955
;;^UTILITY(U,$J,358.3,22425,0)
;;=C22.0^^71^914^91
;;^UTILITY(U,$J,358.3,22425,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22425,1,3,0)
;;=3^Hepatocellular Carcinoma
;;^UTILITY(U,$J,358.3,22425,1,4,0)
;;=4^C22.0
;;^UTILITY(U,$J,358.3,22425,2)
;;=^5000933
;;^UTILITY(U,$J,358.3,22426,0)
;;=C24.9^^71^914^118
;;^UTILITY(U,$J,358.3,22426,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22426,1,3,0)
;;=3^Malig Neop Biliary Tract,Unspec
;;^UTILITY(U,$J,358.3,22426,1,4,0)
;;=4^C24.9
;;^UTILITY(U,$J,358.3,22426,2)
;;=^5000942
;;^UTILITY(U,$J,358.3,22427,0)
;;=C50.922^^71^914^142
;;^UTILITY(U,$J,358.3,22427,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22427,1,3,0)
;;=3^Malig Neop Left Male Breast,Unspec Site
;;^UTILITY(U,$J,358.3,22427,1,4,0)
;;=4^C50.922
;;^UTILITY(U,$J,358.3,22427,2)
;;=^5133340
;;^UTILITY(U,$J,358.3,22428,0)
;;=C34.91^^71^914^160
;;^UTILITY(U,$J,358.3,22428,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22428,1,3,0)
;;=3^Malig Neop Right Bronchus/Lung,Unspec Part
;;^UTILITY(U,$J,358.3,22428,1,4,0)
;;=4^C34.91
;;^UTILITY(U,$J,358.3,22428,2)
;;=^5000967
;;^UTILITY(U,$J,358.3,22429,0)
;;=C50.921^^71^914^164
;;^UTILITY(U,$J,358.3,22429,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22429,1,3,0)
;;=3^Malig Neop Right Male Breast,Unspec Site
;;^UTILITY(U,$J,358.3,22429,1,4,0)
;;=4^C50.921
;;^UTILITY(U,$J,358.3,22429,2)
;;=^5001198
;;^UTILITY(U,$J,358.3,22430,0)
;;=C90.02^^71^914^176
;;^UTILITY(U,$J,358.3,22430,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22430,1,3,0)
;;=3^Multiple Myeloma,In Relapse
;;^UTILITY(U,$J,358.3,22430,1,4,0)
;;=4^C90.02
;;^UTILITY(U,$J,358.3,22430,2)
;;=^5001753
;;^UTILITY(U,$J,358.3,22431,0)
;;=D51.9^^71^914^25
;;^UTILITY(U,$J,358.3,22431,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22431,1,3,0)
;;=3^Anemia in Vitamin B12 Deficiency
;;^UTILITY(U,$J,358.3,22431,1,4,0)
;;=4^D51.9
;;^UTILITY(U,$J,358.3,22431,2)
;;=^5002289
;;^UTILITY(U,$J,358.3,22432,0)
;;=C79.51^^71^914^35
;;^UTILITY(U,$J,358.3,22432,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22432,1,3,0)
;;=3^Bone Mets
;;^UTILITY(U,$J,358.3,22432,1,4,0)
;;=4^C79.51
;;^UTILITY(U,$J,358.3,22432,2)
;;=^5001350
;;^UTILITY(U,$J,358.3,22433,0)
;;=C80.1^^71^914^171
;;^UTILITY(U,$J,358.3,22433,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22433,1,3,0)
;;=3^Malig Neop,Primary,Unspec Site
;;^UTILITY(U,$J,358.3,22433,1,4,0)
;;=4^C80.1
;;^UTILITY(U,$J,358.3,22433,2)
;;=^5001389
;;^UTILITY(U,$J,358.3,22434,0)
;;=C80.0^^71^914^172
;;^UTILITY(U,$J,358.3,22434,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22434,1,3,0)
;;=3^Malig Neop,Unspec Primary or Secondary
;;^UTILITY(U,$J,358.3,22434,1,4,0)
;;=4^C80.0
;;^UTILITY(U,$J,358.3,22434,2)
;;=^5001388
;;^UTILITY(U,$J,358.3,22435,0)
;;=E28.39^^71^914^96
;;^UTILITY(U,$J,358.3,22435,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22435,1,3,0)
;;=3^Hypogonadism,Ovarian
;;^UTILITY(U,$J,358.3,22435,1,4,0)
;;=4^E28.39
;;^UTILITY(U,$J,358.3,22435,2)
;;=^5002752
;;^UTILITY(U,$J,358.3,22436,0)
;;=E29.1^^71^914^97
;;^UTILITY(U,$J,358.3,22436,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22436,1,3,0)
;;=3^Hypogonadism,Testicular
;;^UTILITY(U,$J,358.3,22436,1,4,0)
;;=4^E29.1
;;^UTILITY(U,$J,358.3,22436,2)
;;=^5002754
;;^UTILITY(U,$J,358.3,22437,0)
;;=C96.20^^71^914^111
;;^UTILITY(U,$J,358.3,22437,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22437,1,3,0)
;;=3^Malig Mast Cell Neoplasm,Unspec
;;^UTILITY(U,$J,358.3,22437,1,4,0)
;;=4^C96.20
;;^UTILITY(U,$J,358.3,22437,2)
;;=^5151293
;;^UTILITY(U,$J,358.3,22438,0)
;;=C96.22^^71^914^173
;;^UTILITY(U,$J,358.3,22438,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22438,1,3,0)
;;=3^Mast Cell Sarcoma
;;^UTILITY(U,$J,358.3,22438,1,4,0)
;;=4^C96.22
;;^UTILITY(U,$J,358.3,22438,2)
;;=^5151295
;;^UTILITY(U,$J,358.3,22439,0)
;;=D64.9^^71^914^26
;;^UTILITY(U,$J,358.3,22439,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22439,1,3,0)
;;=3^Anemia,Unspec
;;^UTILITY(U,$J,358.3,22439,1,4,0)
;;=4^D64.9
;;^UTILITY(U,$J,358.3,22439,2)
;;=^5002351
;;^UTILITY(U,$J,358.3,22440,0)
;;=D59.10^^71^914^32
;;^UTILITY(U,$J,358.3,22440,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22440,1,3,0)
;;=3^Autoimmune Hemolytic Anemia,Unspec
;;^UTILITY(U,$J,358.3,22440,1,4,0)
;;=4^D59.10
;;^UTILITY(U,$J,358.3,22440,2)
;;=^5159101
;;^UTILITY(U,$J,358.3,22441,0)
;;=D59.11^^71^914^33
;;^UTILITY(U,$J,358.3,22441,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22441,1,3,0)
;;=3^Autoimmune Hemolytic Anemia,Warm
;;^UTILITY(U,$J,358.3,22441,1,4,0)
;;=4^D59.11
;;^UTILITY(U,$J,358.3,22441,2)
;;=^5159102
;;^UTILITY(U,$J,358.3,22442,0)
;;=D59.12^^71^914^29
;;^UTILITY(U,$J,358.3,22442,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22442,1,3,0)
;;=3^Autoimmune Hemolytic Anemia,Cold
;;^UTILITY(U,$J,358.3,22442,1,4,0)
;;=4^D59.12
;;^UTILITY(U,$J,358.3,22442,2)
;;=^5159103
;;^UTILITY(U,$J,358.3,22443,0)
;;=D59.13^^71^914^30
;;^UTILITY(U,$J,358.3,22443,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22443,1,3,0)
;;=3^Autoimmune Hemolytic Anemia,Mixed Type
;;^UTILITY(U,$J,358.3,22443,1,4,0)
;;=4^D59.13
;;^UTILITY(U,$J,358.3,22443,2)
;;=^5159104
;;^UTILITY(U,$J,358.3,22444,0)
;;=D59.19^^71^914^31
;;^UTILITY(U,$J,358.3,22444,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22444,1,3,0)
;;=3^Autoimmune Hemolytic Anemia,Other
;;^UTILITY(U,$J,358.3,22444,1,4,0)
;;=4^D59.19
;;^UTILITY(U,$J,358.3,22444,2)
;;=^5159105
;;^UTILITY(U,$J,358.3,22445,0)
;;=D57.20^^71^914^201
;;^UTILITY(U,$J,358.3,22445,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22445,1,3,0)
;;=3^Sickle-Cell/Hb-C Disease w/o Crisis
;;^UTILITY(U,$J,358.3,22445,1,4,0)
;;=4^D57.20
;;^UTILITY(U,$J,358.3,22445,2)
;;=^330080
;;^UTILITY(U,$J,358.3,22446,0)
;;=D57.211^^71^914^196
;;^UTILITY(U,$J,358.3,22446,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22446,1,3,0)
;;=3^Sickle-Cell/Hb-C Disease w/ Acute Chest Syndrome
;;^UTILITY(U,$J,358.3,22446,1,4,0)
;;=4^D57.211
;;^UTILITY(U,$J,358.3,22446,2)
;;=^5002310
;;^UTILITY(U,$J,358.3,22447,0)
;;=D57.212^^71^914^200
;;^UTILITY(U,$J,358.3,22447,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22447,1,3,0)
;;=3^Sickle-Cell/Hb-C Disease w/ Splenic Sequestration
;;^UTILITY(U,$J,358.3,22447,1,4,0)
;;=4^D57.212
;;^UTILITY(U,$J,358.3,22447,2)
;;=^5002311
;;^UTILITY(U,$J,358.3,22448,0)
;;=D57.213^^71^914^197
;;^UTILITY(U,$J,358.3,22448,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22448,1,3,0)
;;=3^Sickle-Cell/Hb-C Disease w/ Cerebral Vascular Involvement
;;^UTILITY(U,$J,358.3,22448,1,4,0)
;;=4^D57.213
;;^UTILITY(U,$J,358.3,22448,2)
;;=^5159080
;;^UTILITY(U,$J,358.3,22449,0)
;;=D57.218^^71^914^198
;;^UTILITY(U,$J,358.3,22449,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22449,1,3,0)
;;=3^Sickle-Cell/Hb-C Disease w/ Crisis w/ Oth Complication
;;^UTILITY(U,$J,358.3,22449,1,4,0)
;;=4^D57.218
;;^UTILITY(U,$J,358.3,22449,2)
;;=^5159081
;;^UTILITY(U,$J,358.3,22450,0)
;;=D57.219^^71^914^199
;;^UTILITY(U,$J,358.3,22450,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22450,1,3,0)
;;=3^Sickle-Cell/Hb-C Disease w/ Crisis,Unspec
;;^UTILITY(U,$J,358.3,22450,1,4,0)
;;=4^D57.219
;;^UTILITY(U,$J,358.3,22450,2)
;;=^5002312
;;^UTILITY(U,$J,358.3,22451,0)
;;=D57.3^^71^914^195
;;^UTILITY(U,$J,358.3,22451,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22451,1,3,0)
;;=3^Sickle-Cell Trait
;;^UTILITY(U,$J,358.3,22451,1,4,0)
;;=4^D57.3
;;^UTILITY(U,$J,358.3,22451,2)
;;=^5002313
;;^UTILITY(U,$J,358.3,22452,0)
;;=D57.40^^71^914^192
;;^UTILITY(U,$J,358.3,22452,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22452,1,3,0)
;;=3^Sickle-Cell Thalassemia w/o Crisis
;;^UTILITY(U,$J,358.3,22452,1,4,0)
;;=4^D57.40
;;^UTILITY(U,$J,358.3,22452,2)
;;=^329908
;;^UTILITY(U,$J,358.3,22453,0)
;;=D57.411^^71^914^193
;;^UTILITY(U,$J,358.3,22453,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22453,1,3,0)
;;=3^Sickle-Cell Thalassemia,Unspec w/ Acute Chest Syndrome
;;^UTILITY(U,$J,358.3,22453,1,4,0)
;;=4^D57.411
;;^UTILITY(U,$J,358.3,22453,2)
;;=^5002314
;;^UTILITY(U,$J,358.3,22454,0)
;;=D57.412^^71^914^194
;;^UTILITY(U,$J,358.3,22454,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22454,1,3,0)
;;=3^Sickle-Cell Thalassemia,Unspec w/ Splenic Sequestration
;;^UTILITY(U,$J,358.3,22454,1,4,0)
;;=4^D57.412
;;^UTILITY(U,$J,358.3,22454,2)
;;=^5002315
;;^UTILITY(U,$J,358.3,22455,0)
;;=M31.10^^71^914^215
;;^UTILITY(U,$J,358.3,22455,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22455,1,3,0)
;;=3^Thrombotic Microangiopathy,Unspec
;;^UTILITY(U,$J,358.3,22455,1,4,0)
;;=4^M31.10
;;^UTILITY(U,$J,358.3,22455,2)
;;=^5161189
;;^UTILITY(U,$J,358.3,22456,0)
;;=Z85.818^^71^915^86
;;^UTILITY(U,$J,358.3,22456,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22456,1,3,0)
;;=3^Personal Hx of Malig Neop of Lip,Oral Cavity & Pharynx
;;^UTILITY(U,$J,358.3,22456,1,4,0)
;;=4^Z85.818
;;^UTILITY(U,$J,358.3,22456,2)
;;=^5063439
;;^UTILITY(U,$J,358.3,22457,0)
;;=Z85.819^^71^915^87
;;^UTILITY(U,$J,358.3,22457,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22457,1,3,0)
;;=3^Personal Hx of Malig Neop of Lip,Oral Cavity & Pharynx,Unspec
;;^UTILITY(U,$J,358.3,22457,1,4,0)
;;=4^Z85.819
;;^UTILITY(U,$J,358.3,22457,2)
;;=^5063440
;;^UTILITY(U,$J,358.3,22458,0)
;;=Z85.01^^71^915^82
;;^UTILITY(U,$J,358.3,22458,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22458,1,3,0)
;;=3^Personal Hx of Malig Neop of Esophagus
;;^UTILITY(U,$J,358.3,22458,1,4,0)
;;=4^Z85.01
;;^UTILITY(U,$J,358.3,22458,2)
;;=^5063395
;;^UTILITY(U,$J,358.3,22459,0)
;;=Z85.028^^71^915^93
;;^UTILITY(U,$J,358.3,22459,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22459,1,3,0)
;;=3^Personal Hx of Malig Neop of Stomach
;;^UTILITY(U,$J,358.3,22459,1,4,0)
;;=4^Z85.028
;;^UTILITY(U,$J,358.3,22459,2)
;;=^5063397
;;^UTILITY(U,$J,358.3,22460,0)
;;=Z85.038^^71^915^84
;;^UTILITY(U,$J,358.3,22460,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22460,1,3,0)
;;=3^Personal Hx of Malig Neop of Large Intestine
;;^UTILITY(U,$J,358.3,22460,1,4,0)
;;=4^Z85.038
;;^UTILITY(U,$J,358.3,22460,2)
;;=^5063399
;;^UTILITY(U,$J,358.3,22461,0)
;;=Z85.048^^71^915^91
;;^UTILITY(U,$J,358.3,22461,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22461,1,3,0)
;;=3^Personal Hx of Malig Neop of Rectum,Rectosig Junct & Anus
;;^UTILITY(U,$J,358.3,22461,1,4,0)
;;=4^Z85.048
;;^UTILITY(U,$J,358.3,22461,2)
;;=^5063401
;;^UTILITY(U,$J,358.3,22462,0)
;;=Z85.118^^71^915^80
;;^UTILITY(U,$J,358.3,22462,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22462,1,3,0)
;;=3^Personal Hx of Malig Neop of Bronchus & Lung
;;^UTILITY(U,$J,358.3,22462,1,4,0)
;;=4^Z85.118
;;^UTILITY(U,$J,358.3,22462,2)
;;=^5063408
;;^UTILITY(U,$J,358.3,22463,0)
;;=Z85.21^^71^915^85
;;^UTILITY(U,$J,358.3,22463,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22463,1,3,0)
;;=3^Personal Hx of Malig Neop of Larynx
;;^UTILITY(U,$J,358.3,22463,1,4,0)
;;=4^Z85.21
;;^UTILITY(U,$J,358.3,22463,2)
;;=^5063411
;;^UTILITY(U,$J,358.3,22464,0)
;;=Z85.3^^71^915^79
;;^UTILITY(U,$J,358.3,22464,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22464,1,3,0)
;;=3^Personal Hx of Malig Neop of Breast
;;^UTILITY(U,$J,358.3,22464,1,4,0)
;;=4^Z85.3
;;^UTILITY(U,$J,358.3,22464,2)
;;=^5063416
;;^UTILITY(U,$J,358.3,22465,0)
;;=Z85.41^^71^915^81
;;^UTILITY(U,$J,358.3,22465,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22465,1,3,0)
;;=3^Personal Hx of Malig Neop of Cervix Uteri
;;^UTILITY(U,$J,358.3,22465,1,4,0)
;;=4^Z85.41
;;^UTILITY(U,$J,358.3,22465,2)
;;=^5063418
;;^UTILITY(U,$J,358.3,22466,0)
;;=Z85.43^^71^915^89
;;^UTILITY(U,$J,358.3,22466,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22466,1,3,0)
;;=3^Personal Hx of Malig Neop of Ovary
;;^UTILITY(U,$J,358.3,22466,1,4,0)
;;=4^Z85.43
;;^UTILITY(U,$J,358.3,22466,2)
;;=^5063420
;;^UTILITY(U,$J,358.3,22467,0)
;;=Z85.46^^71^915^90
;;^UTILITY(U,$J,358.3,22467,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22467,1,3,0)
;;=3^Personal Hx of Malig Neop of Prostate
;;^UTILITY(U,$J,358.3,22467,1,4,0)
;;=4^Z85.46
;;^UTILITY(U,$J,358.3,22467,2)
;;=^5063423
;;^UTILITY(U,$J,358.3,22468,0)
;;=Z85.47^^71^915^94
;;^UTILITY(U,$J,358.3,22468,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22468,1,3,0)
;;=3^Personal Hx of Malig Neop of Testis
;;^UTILITY(U,$J,358.3,22468,1,4,0)
;;=4^Z85.47
;;^UTILITY(U,$J,358.3,22468,2)
;;=^5063424
;;^UTILITY(U,$J,358.3,22469,0)
;;=Z85.51^^71^915^78
;;^UTILITY(U,$J,358.3,22469,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22469,1,3,0)
;;=3^Personal Hx of Malig Neop of Bladder
;;^UTILITY(U,$J,358.3,22469,1,4,0)
;;=4^Z85.51
;;^UTILITY(U,$J,358.3,22469,2)
;;=^5063428
;;^UTILITY(U,$J,358.3,22470,0)
;;=Z85.528^^71^915^83
;;^UTILITY(U,$J,358.3,22470,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22470,1,3,0)
;;=3^Personal Hx of Malig Neop of Kidney
;;^UTILITY(U,$J,358.3,22470,1,4,0)
;;=4^Z85.528
;;^UTILITY(U,$J,358.3,22470,2)
;;=^5063430
;;^UTILITY(U,$J,358.3,22471,0)
;;=Z85.6^^71^915^74
;;^UTILITY(U,$J,358.3,22471,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22471,1,3,0)
;;=3^Personal Hx of Leukemia
;;^UTILITY(U,$J,358.3,22471,1,4,0)
;;=4^Z85.6
;;^UTILITY(U,$J,358.3,22471,2)
;;=^5063434
;;^UTILITY(U,$J,358.3,22472,0)
;;=Z85.72^^71^915^98
;;^UTILITY(U,$J,358.3,22472,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22472,1,3,0)
;;=3^Personal Hx of Non-Hodgkin Lymphomas
;;^UTILITY(U,$J,358.3,22472,1,4,0)
;;=4^Z85.72
;;^UTILITY(U,$J,358.3,22472,2)
;;=^5063436
;;^UTILITY(U,$J,358.3,22473,0)
;;=Z85.79^^71^915^88
;;^UTILITY(U,$J,358.3,22473,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22473,1,3,0)
;;=3^Personal Hx of Malig Neop of Lymphoid,Hematpoetc & Rel Tissue
;;^UTILITY(U,$J,358.3,22473,1,4,0)
;;=4^Z85.79
;;^UTILITY(U,$J,358.3,22473,2)
;;=^5063437
;;^UTILITY(U,$J,358.3,22474,0)
;;=Z85.820^^71^915^77
;;^UTILITY(U,$J,358.3,22474,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22474,1,3,0)
;;=3^Personal Hx of Malig Melanoma of Skin
;;^UTILITY(U,$J,358.3,22474,1,4,0)
;;=4^Z85.820
;;^UTILITY(U,$J,358.3,22474,2)
;;=^5063441
;;^UTILITY(U,$J,358.3,22475,0)
;;=Z85.828^^71^915^92
;;^UTILITY(U,$J,358.3,22475,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22475,1,3,0)
;;=3^Personal Hx of Malig Neop of Skin
;;^UTILITY(U,$J,358.3,22475,1,4,0)
;;=4^Z85.828
;;^UTILITY(U,$J,358.3,22475,2)
;;=^5063443
;;^UTILITY(U,$J,358.3,22476,0)
;;=Z85.71^^71^915^72
;;^UTILITY(U,$J,358.3,22476,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22476,1,3,0)
;;=3^Personal Hx of Hodgkin Lymphoma
;;^UTILITY(U,$J,358.3,22476,1,4,0)
;;=4^Z85.71
;;^UTILITY(U,$J,358.3,22476,2)
;;=^5063435
;;^UTILITY(U,$J,358.3,22477,0)
;;=Z65.8^^71^915^144
;;^UTILITY(U,$J,358.3,22477,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22477,1,3,0)
;;=3^Psychosocial Circumstance Related Problems
;;^UTILITY(U,$J,358.3,22477,1,4,0)
;;=4^Z65.8
;;^UTILITY(U,$J,358.3,22477,2)
;;=^5063185
;;^UTILITY(U,$J,358.3,22478,0)
;;=Z86.11^^71^915^109
;;^UTILITY(U,$J,358.3,22478,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22478,1,3,0)
;;=3^Personal Hx of Tuberculosis
;;^UTILITY(U,$J,358.3,22478,1,4,0)
;;=4^Z86.11
;;^UTILITY(U,$J,358.3,22478,2)
;;=^5063461
;;^UTILITY(U,$J,358.3,22479,0)
;;=Z86.13^^71^915^76
;;^UTILITY(U,$J,358.3,22479,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22479,1,3,0)
;;=3^Personal Hx of Malaria
;;^UTILITY(U,$J,358.3,22479,1,4,0)
;;=4^Z86.13
;;^UTILITY(U,$J,358.3,22479,2)
;;=^5063463
;;^UTILITY(U,$J,358.3,22480,0)
;;=Z86.73^^71^915^106
;;^UTILITY(U,$J,358.3,22480,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22480,1,3,0)
;;=3^Personal Hx of TIA & Cereb Infrc w/o Residual Deficits
;;^UTILITY(U,$J,358.3,22480,1,4,0)
;;=4^Z86.73
;;^UTILITY(U,$J,358.3,22480,2)
;;=^5063477
;;^UTILITY(U,$J,358.3,22481,0)
;;=Z86.79^^71^915^69
;;^UTILITY(U,$J,358.3,22481,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22481,1,3,0)
;;=3^Personal Hx of Circulatory System Diseases
;;^UTILITY(U,$J,358.3,22481,1,4,0)
;;=4^Z86.79
;;^UTILITY(U,$J,358.3,22481,2)
;;=^5063479
;;^UTILITY(U,$J,358.3,22482,0)
;;=Z91.040^^71^915^57
;;^UTILITY(U,$J,358.3,22482,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22482,1,3,0)
;;=3^Latex Allergy Status
;;^UTILITY(U,$J,358.3,22482,1,4,0)
;;=4^Z91.040
;;^UTILITY(U,$J,358.3,22482,2)
;;=^5063607
;;^UTILITY(U,$J,358.3,22483,0)
;;=Z92.3^^71^915^73
;;^UTILITY(U,$J,358.3,22483,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22483,1,3,0)
;;=3^Personal Hx of Irradiation
;;^UTILITY(U,$J,358.3,22483,1,4,0)
;;=4^Z92.3
;;^UTILITY(U,$J,358.3,22483,2)
;;=^5063637
;;^UTILITY(U,$J,358.3,22484,0)
;;=Z91.120^^71^915^53
;;^UTILITY(U,$J,358.3,22484,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22484,1,3,0)
;;=3^Intentional Underdose of Meds d/t Financial Hardship
;;^UTILITY(U,$J,358.3,22484,1,4,0)
;;=4^Z91.120
;;^UTILITY(U,$J,358.3,22484,2)
;;=^5063612
;;^UTILITY(U,$J,358.3,22485,0)
;;=Z91.11^^71^915^62
;;^UTILITY(U,$J,358.3,22485,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22485,1,3,0)
;;=3^Noncompliance w/ Dietary Regimen
;;^UTILITY(U,$J,358.3,22485,1,4,0)
;;=4^Z91.11
;;^UTILITY(U,$J,358.3,22485,2)
;;=^5063611
;;^UTILITY(U,$J,358.3,22486,0)
;;=Z87.891^^71^915^97
;;^UTILITY(U,$J,358.3,22486,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22486,1,3,0)
;;=3^Personal Hx of Nicotine Dependence
;;^UTILITY(U,$J,358.3,22486,1,4,0)
;;=4^Z87.891
;;^UTILITY(U,$J,358.3,22486,2)
;;=^5063518
;;^UTILITY(U,$J,358.3,22487,0)
;;=Z77.090^^71^915^3
;;^UTILITY(U,$J,358.3,22487,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22487,1,3,0)
;;=3^Asbestos Contact/Exposure
;;^UTILITY(U,$J,358.3,22487,1,4,0)
;;=4^Z77.090
;;^UTILITY(U,$J,358.3,22487,2)
;;=^5063312
;;^UTILITY(U,$J,358.3,22488,0)
;;=Z57.8^^71^915^65
;;^UTILITY(U,$J,358.3,22488,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22488,1,3,0)
;;=3^Occupational Exposure to Other Risk Factors
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI096 19819 printed Sep 23, 2025@19:20:05 Page 2
IBDEI096 ; ; 01-AUG-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;AUG 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,22421,1,0)
+2 ;;=^358.31IA^4^2
+3 ;;^UTILITY(U,$J,358.3,22421,1,3,0)
+4 ;;=3^Waldenstrom Macroglobulinemia
+5 ;;^UTILITY(U,$J,358.3,22421,1,4,0)
+6 ;;=4^C88.0
+7 ;;^UTILITY(U,$J,358.3,22421,2)
+8 ;;=^5001748
+9 ;;^UTILITY(U,$J,358.3,22422,0)
+10 ;;=C91.02^^71^914^3
+11 ;;^UTILITY(U,$J,358.3,22422,1,0)
+12 ;;=^358.31IA^4^2
+13 ;;^UTILITY(U,$J,358.3,22422,1,3,0)
+14 ;;=3^Acute Lymphoblastic Leukemia,In Relapse
+15 ;;^UTILITY(U,$J,358.3,22422,1,4,0)
+16 ;;=4^C91.02
+17 ;;^UTILITY(U,$J,358.3,22422,2)
+18 ;;=^5001764
+19 ;;^UTILITY(U,$J,358.3,22423,0)
+20 ;;=C92.02^^71^914^6
+21 ;;^UTILITY(U,$J,358.3,22423,1,0)
+22 ;;=^358.31IA^4^2
+23 ;;^UTILITY(U,$J,358.3,22423,1,3,0)
+24 ;;=3^Acute Myeloblastic Leukemia,In Relapse
+25 ;;^UTILITY(U,$J,358.3,22423,1,4,0)
+26 ;;=4^C92.02
+27 ;;^UTILITY(U,$J,358.3,22423,2)
+28 ;;=^5001791
+29 ;;^UTILITY(U,$J,358.3,22424,0)
+30 ;;=D09.3^^71^914^50
+31 ;;^UTILITY(U,$J,358.3,22424,1,0)
+32 ;;=^358.31IA^4^2
+33 ;;^UTILITY(U,$J,358.3,22424,1,3,0)
+34 ;;=3^Carcinoma in Situ of Thyroid/Oth Endocrine Glands
+35 ;;^UTILITY(U,$J,358.3,22424,1,4,0)
+36 ;;=4^D09.3
+37 ;;^UTILITY(U,$J,358.3,22424,2)
+38 ;;=^5001955
+39 ;;^UTILITY(U,$J,358.3,22425,0)
+40 ;;=C22.0^^71^914^91
+41 ;;^UTILITY(U,$J,358.3,22425,1,0)
+42 ;;=^358.31IA^4^2
+43 ;;^UTILITY(U,$J,358.3,22425,1,3,0)
+44 ;;=3^Hepatocellular Carcinoma
+45 ;;^UTILITY(U,$J,358.3,22425,1,4,0)
+46 ;;=4^C22.0
+47 ;;^UTILITY(U,$J,358.3,22425,2)
+48 ;;=^5000933
+49 ;;^UTILITY(U,$J,358.3,22426,0)
+50 ;;=C24.9^^71^914^118
+51 ;;^UTILITY(U,$J,358.3,22426,1,0)
+52 ;;=^358.31IA^4^2
+53 ;;^UTILITY(U,$J,358.3,22426,1,3,0)
+54 ;;=3^Malig Neop Biliary Tract,Unspec
+55 ;;^UTILITY(U,$J,358.3,22426,1,4,0)
+56 ;;=4^C24.9
+57 ;;^UTILITY(U,$J,358.3,22426,2)
+58 ;;=^5000942
+59 ;;^UTILITY(U,$J,358.3,22427,0)
+60 ;;=C50.922^^71^914^142
+61 ;;^UTILITY(U,$J,358.3,22427,1,0)
+62 ;;=^358.31IA^4^2
+63 ;;^UTILITY(U,$J,358.3,22427,1,3,0)
+64 ;;=3^Malig Neop Left Male Breast,Unspec Site
+65 ;;^UTILITY(U,$J,358.3,22427,1,4,0)
+66 ;;=4^C50.922
+67 ;;^UTILITY(U,$J,358.3,22427,2)
+68 ;;=^5133340
+69 ;;^UTILITY(U,$J,358.3,22428,0)
+70 ;;=C34.91^^71^914^160
+71 ;;^UTILITY(U,$J,358.3,22428,1,0)
+72 ;;=^358.31IA^4^2
+73 ;;^UTILITY(U,$J,358.3,22428,1,3,0)
+74 ;;=3^Malig Neop Right Bronchus/Lung,Unspec Part
+75 ;;^UTILITY(U,$J,358.3,22428,1,4,0)
+76 ;;=4^C34.91
+77 ;;^UTILITY(U,$J,358.3,22428,2)
+78 ;;=^5000967
+79 ;;^UTILITY(U,$J,358.3,22429,0)
+80 ;;=C50.921^^71^914^164
+81 ;;^UTILITY(U,$J,358.3,22429,1,0)
+82 ;;=^358.31IA^4^2
+83 ;;^UTILITY(U,$J,358.3,22429,1,3,0)
+84 ;;=3^Malig Neop Right Male Breast,Unspec Site
+85 ;;^UTILITY(U,$J,358.3,22429,1,4,0)
+86 ;;=4^C50.921
+87 ;;^UTILITY(U,$J,358.3,22429,2)
+88 ;;=^5001198
+89 ;;^UTILITY(U,$J,358.3,22430,0)
+90 ;;=C90.02^^71^914^176
+91 ;;^UTILITY(U,$J,358.3,22430,1,0)
+92 ;;=^358.31IA^4^2
+93 ;;^UTILITY(U,$J,358.3,22430,1,3,0)
+94 ;;=3^Multiple Myeloma,In Relapse
+95 ;;^UTILITY(U,$J,358.3,22430,1,4,0)
+96 ;;=4^C90.02
+97 ;;^UTILITY(U,$J,358.3,22430,2)
+98 ;;=^5001753
+99 ;;^UTILITY(U,$J,358.3,22431,0)
+100 ;;=D51.9^^71^914^25
+101 ;;^UTILITY(U,$J,358.3,22431,1,0)
+102 ;;=^358.31IA^4^2
+103 ;;^UTILITY(U,$J,358.3,22431,1,3,0)
+104 ;;=3^Anemia in Vitamin B12 Deficiency
+105 ;;^UTILITY(U,$J,358.3,22431,1,4,0)
+106 ;;=4^D51.9
+107 ;;^UTILITY(U,$J,358.3,22431,2)
+108 ;;=^5002289
+109 ;;^UTILITY(U,$J,358.3,22432,0)
+110 ;;=C79.51^^71^914^35
+111 ;;^UTILITY(U,$J,358.3,22432,1,0)
+112 ;;=^358.31IA^4^2
+113 ;;^UTILITY(U,$J,358.3,22432,1,3,0)
+114 ;;=3^Bone Mets
+115 ;;^UTILITY(U,$J,358.3,22432,1,4,0)
+116 ;;=4^C79.51
+117 ;;^UTILITY(U,$J,358.3,22432,2)
+118 ;;=^5001350
+119 ;;^UTILITY(U,$J,358.3,22433,0)
+120 ;;=C80.1^^71^914^171
+121 ;;^UTILITY(U,$J,358.3,22433,1,0)
+122 ;;=^358.31IA^4^2
+123 ;;^UTILITY(U,$J,358.3,22433,1,3,0)
+124 ;;=3^Malig Neop,Primary,Unspec Site
+125 ;;^UTILITY(U,$J,358.3,22433,1,4,0)
+126 ;;=4^C80.1
+127 ;;^UTILITY(U,$J,358.3,22433,2)
+128 ;;=^5001389
+129 ;;^UTILITY(U,$J,358.3,22434,0)
+130 ;;=C80.0^^71^914^172
+131 ;;^UTILITY(U,$J,358.3,22434,1,0)
+132 ;;=^358.31IA^4^2
+133 ;;^UTILITY(U,$J,358.3,22434,1,3,0)
+134 ;;=3^Malig Neop,Unspec Primary or Secondary
+135 ;;^UTILITY(U,$J,358.3,22434,1,4,0)
+136 ;;=4^C80.0
+137 ;;^UTILITY(U,$J,358.3,22434,2)
+138 ;;=^5001388
+139 ;;^UTILITY(U,$J,358.3,22435,0)
+140 ;;=E28.39^^71^914^96
+141 ;;^UTILITY(U,$J,358.3,22435,1,0)
+142 ;;=^358.31IA^4^2
+143 ;;^UTILITY(U,$J,358.3,22435,1,3,0)
+144 ;;=3^Hypogonadism,Ovarian
+145 ;;^UTILITY(U,$J,358.3,22435,1,4,0)
+146 ;;=4^E28.39
+147 ;;^UTILITY(U,$J,358.3,22435,2)
+148 ;;=^5002752
+149 ;;^UTILITY(U,$J,358.3,22436,0)
+150 ;;=E29.1^^71^914^97
+151 ;;^UTILITY(U,$J,358.3,22436,1,0)
+152 ;;=^358.31IA^4^2
+153 ;;^UTILITY(U,$J,358.3,22436,1,3,0)
+154 ;;=3^Hypogonadism,Testicular
+155 ;;^UTILITY(U,$J,358.3,22436,1,4,0)
+156 ;;=4^E29.1
+157 ;;^UTILITY(U,$J,358.3,22436,2)
+158 ;;=^5002754
+159 ;;^UTILITY(U,$J,358.3,22437,0)
+160 ;;=C96.20^^71^914^111
+161 ;;^UTILITY(U,$J,358.3,22437,1,0)
+162 ;;=^358.31IA^4^2
+163 ;;^UTILITY(U,$J,358.3,22437,1,3,0)
+164 ;;=3^Malig Mast Cell Neoplasm,Unspec
+165 ;;^UTILITY(U,$J,358.3,22437,1,4,0)
+166 ;;=4^C96.20
+167 ;;^UTILITY(U,$J,358.3,22437,2)
+168 ;;=^5151293
+169 ;;^UTILITY(U,$J,358.3,22438,0)
+170 ;;=C96.22^^71^914^173
+171 ;;^UTILITY(U,$J,358.3,22438,1,0)
+172 ;;=^358.31IA^4^2
+173 ;;^UTILITY(U,$J,358.3,22438,1,3,0)
+174 ;;=3^Mast Cell Sarcoma
+175 ;;^UTILITY(U,$J,358.3,22438,1,4,0)
+176 ;;=4^C96.22
+177 ;;^UTILITY(U,$J,358.3,22438,2)
+178 ;;=^5151295
+179 ;;^UTILITY(U,$J,358.3,22439,0)
+180 ;;=D64.9^^71^914^26
+181 ;;^UTILITY(U,$J,358.3,22439,1,0)
+182 ;;=^358.31IA^4^2
+183 ;;^UTILITY(U,$J,358.3,22439,1,3,0)
+184 ;;=3^Anemia,Unspec
+185 ;;^UTILITY(U,$J,358.3,22439,1,4,0)
+186 ;;=4^D64.9
+187 ;;^UTILITY(U,$J,358.3,22439,2)
+188 ;;=^5002351
+189 ;;^UTILITY(U,$J,358.3,22440,0)
+190 ;;=D59.10^^71^914^32
+191 ;;^UTILITY(U,$J,358.3,22440,1,0)
+192 ;;=^358.31IA^4^2
+193 ;;^UTILITY(U,$J,358.3,22440,1,3,0)
+194 ;;=3^Autoimmune Hemolytic Anemia,Unspec
+195 ;;^UTILITY(U,$J,358.3,22440,1,4,0)
+196 ;;=4^D59.10
+197 ;;^UTILITY(U,$J,358.3,22440,2)
+198 ;;=^5159101
+199 ;;^UTILITY(U,$J,358.3,22441,0)
+200 ;;=D59.11^^71^914^33
+201 ;;^UTILITY(U,$J,358.3,22441,1,0)
+202 ;;=^358.31IA^4^2
+203 ;;^UTILITY(U,$J,358.3,22441,1,3,0)
+204 ;;=3^Autoimmune Hemolytic Anemia,Warm
+205 ;;^UTILITY(U,$J,358.3,22441,1,4,0)
+206 ;;=4^D59.11
+207 ;;^UTILITY(U,$J,358.3,22441,2)
+208 ;;=^5159102
+209 ;;^UTILITY(U,$J,358.3,22442,0)
+210 ;;=D59.12^^71^914^29
+211 ;;^UTILITY(U,$J,358.3,22442,1,0)
+212 ;;=^358.31IA^4^2
+213 ;;^UTILITY(U,$J,358.3,22442,1,3,0)
+214 ;;=3^Autoimmune Hemolytic Anemia,Cold
+215 ;;^UTILITY(U,$J,358.3,22442,1,4,0)
+216 ;;=4^D59.12
+217 ;;^UTILITY(U,$J,358.3,22442,2)
+218 ;;=^5159103
+219 ;;^UTILITY(U,$J,358.3,22443,0)
+220 ;;=D59.13^^71^914^30
+221 ;;^UTILITY(U,$J,358.3,22443,1,0)
+222 ;;=^358.31IA^4^2
+223 ;;^UTILITY(U,$J,358.3,22443,1,3,0)
+224 ;;=3^Autoimmune Hemolytic Anemia,Mixed Type
+225 ;;^UTILITY(U,$J,358.3,22443,1,4,0)
+226 ;;=4^D59.13
+227 ;;^UTILITY(U,$J,358.3,22443,2)
+228 ;;=^5159104
+229 ;;^UTILITY(U,$J,358.3,22444,0)
+230 ;;=D59.19^^71^914^31
+231 ;;^UTILITY(U,$J,358.3,22444,1,0)
+232 ;;=^358.31IA^4^2
+233 ;;^UTILITY(U,$J,358.3,22444,1,3,0)
+234 ;;=3^Autoimmune Hemolytic Anemia,Other
+235 ;;^UTILITY(U,$J,358.3,22444,1,4,0)
+236 ;;=4^D59.19
+237 ;;^UTILITY(U,$J,358.3,22444,2)
+238 ;;=^5159105
+239 ;;^UTILITY(U,$J,358.3,22445,0)
+240 ;;=D57.20^^71^914^201
+241 ;;^UTILITY(U,$J,358.3,22445,1,0)
+242 ;;=^358.31IA^4^2
+243 ;;^UTILITY(U,$J,358.3,22445,1,3,0)
+244 ;;=3^Sickle-Cell/Hb-C Disease w/o Crisis
+245 ;;^UTILITY(U,$J,358.3,22445,1,4,0)
+246 ;;=4^D57.20
+247 ;;^UTILITY(U,$J,358.3,22445,2)
+248 ;;=^330080
+249 ;;^UTILITY(U,$J,358.3,22446,0)
+250 ;;=D57.211^^71^914^196
+251 ;;^UTILITY(U,$J,358.3,22446,1,0)
+252 ;;=^358.31IA^4^2
+253 ;;^UTILITY(U,$J,358.3,22446,1,3,0)
+254 ;;=3^Sickle-Cell/Hb-C Disease w/ Acute Chest Syndrome
+255 ;;^UTILITY(U,$J,358.3,22446,1,4,0)
+256 ;;=4^D57.211
+257 ;;^UTILITY(U,$J,358.3,22446,2)
+258 ;;=^5002310
+259 ;;^UTILITY(U,$J,358.3,22447,0)
+260 ;;=D57.212^^71^914^200
+261 ;;^UTILITY(U,$J,358.3,22447,1,0)
+262 ;;=^358.31IA^4^2
+263 ;;^UTILITY(U,$J,358.3,22447,1,3,0)
+264 ;;=3^Sickle-Cell/Hb-C Disease w/ Splenic Sequestration
+265 ;;^UTILITY(U,$J,358.3,22447,1,4,0)
+266 ;;=4^D57.212
+267 ;;^UTILITY(U,$J,358.3,22447,2)
+268 ;;=^5002311
+269 ;;^UTILITY(U,$J,358.3,22448,0)
+270 ;;=D57.213^^71^914^197
+271 ;;^UTILITY(U,$J,358.3,22448,1,0)
+272 ;;=^358.31IA^4^2
+273 ;;^UTILITY(U,$J,358.3,22448,1,3,0)
+274 ;;=3^Sickle-Cell/Hb-C Disease w/ Cerebral Vascular Involvement
+275 ;;^UTILITY(U,$J,358.3,22448,1,4,0)
+276 ;;=4^D57.213
+277 ;;^UTILITY(U,$J,358.3,22448,2)
+278 ;;=^5159080
+279 ;;^UTILITY(U,$J,358.3,22449,0)
+280 ;;=D57.218^^71^914^198
+281 ;;^UTILITY(U,$J,358.3,22449,1,0)
+282 ;;=^358.31IA^4^2
+283 ;;^UTILITY(U,$J,358.3,22449,1,3,0)
+284 ;;=3^Sickle-Cell/Hb-C Disease w/ Crisis w/ Oth Complication
+285 ;;^UTILITY(U,$J,358.3,22449,1,4,0)
+286 ;;=4^D57.218
+287 ;;^UTILITY(U,$J,358.3,22449,2)
+288 ;;=^5159081
+289 ;;^UTILITY(U,$J,358.3,22450,0)
+290 ;;=D57.219^^71^914^199
+291 ;;^UTILITY(U,$J,358.3,22450,1,0)
+292 ;;=^358.31IA^4^2
+293 ;;^UTILITY(U,$J,358.3,22450,1,3,0)
+294 ;;=3^Sickle-Cell/Hb-C Disease w/ Crisis,Unspec
+295 ;;^UTILITY(U,$J,358.3,22450,1,4,0)
+296 ;;=4^D57.219
+297 ;;^UTILITY(U,$J,358.3,22450,2)
+298 ;;=^5002312
+299 ;;^UTILITY(U,$J,358.3,22451,0)
+300 ;;=D57.3^^71^914^195
+301 ;;^UTILITY(U,$J,358.3,22451,1,0)
+302 ;;=^358.31IA^4^2
+303 ;;^UTILITY(U,$J,358.3,22451,1,3,0)
+304 ;;=3^Sickle-Cell Trait
+305 ;;^UTILITY(U,$J,358.3,22451,1,4,0)
+306 ;;=4^D57.3
+307 ;;^UTILITY(U,$J,358.3,22451,2)
+308 ;;=^5002313
+309 ;;^UTILITY(U,$J,358.3,22452,0)
+310 ;;=D57.40^^71^914^192
+311 ;;^UTILITY(U,$J,358.3,22452,1,0)
+312 ;;=^358.31IA^4^2
+313 ;;^UTILITY(U,$J,358.3,22452,1,3,0)
+314 ;;=3^Sickle-Cell Thalassemia w/o Crisis
+315 ;;^UTILITY(U,$J,358.3,22452,1,4,0)
+316 ;;=4^D57.40
+317 ;;^UTILITY(U,$J,358.3,22452,2)
+318 ;;=^329908
+319 ;;^UTILITY(U,$J,358.3,22453,0)
+320 ;;=D57.411^^71^914^193
+321 ;;^UTILITY(U,$J,358.3,22453,1,0)
+322 ;;=^358.31IA^4^2
+323 ;;^UTILITY(U,$J,358.3,22453,1,3,0)
+324 ;;=3^Sickle-Cell Thalassemia,Unspec w/ Acute Chest Syndrome
+325 ;;^UTILITY(U,$J,358.3,22453,1,4,0)
+326 ;;=4^D57.411
+327 ;;^UTILITY(U,$J,358.3,22453,2)
+328 ;;=^5002314
+329 ;;^UTILITY(U,$J,358.3,22454,0)
+330 ;;=D57.412^^71^914^194
+331 ;;^UTILITY(U,$J,358.3,22454,1,0)
+332 ;;=^358.31IA^4^2
+333 ;;^UTILITY(U,$J,358.3,22454,1,3,0)
+334 ;;=3^Sickle-Cell Thalassemia,Unspec w/ Splenic Sequestration
+335 ;;^UTILITY(U,$J,358.3,22454,1,4,0)
+336 ;;=4^D57.412
+337 ;;^UTILITY(U,$J,358.3,22454,2)
+338 ;;=^5002315
+339 ;;^UTILITY(U,$J,358.3,22455,0)
+340 ;;=M31.10^^71^914^215
+341 ;;^UTILITY(U,$J,358.3,22455,1,0)
+342 ;;=^358.31IA^4^2
+343 ;;^UTILITY(U,$J,358.3,22455,1,3,0)
+344 ;;=3^Thrombotic Microangiopathy,Unspec
+345 ;;^UTILITY(U,$J,358.3,22455,1,4,0)
+346 ;;=4^M31.10
+347 ;;^UTILITY(U,$J,358.3,22455,2)
+348 ;;=^5161189
+349 ;;^UTILITY(U,$J,358.3,22456,0)
+350 ;;=Z85.818^^71^915^86
+351 ;;^UTILITY(U,$J,358.3,22456,1,0)
+352 ;;=^358.31IA^4^2
+353 ;;^UTILITY(U,$J,358.3,22456,1,3,0)
+354 ;;=3^Personal Hx of Malig Neop of Lip,Oral Cavity & Pharynx
+355 ;;^UTILITY(U,$J,358.3,22456,1,4,0)
+356 ;;=4^Z85.818
+357 ;;^UTILITY(U,$J,358.3,22456,2)
+358 ;;=^5063439
+359 ;;^UTILITY(U,$J,358.3,22457,0)
+360 ;;=Z85.819^^71^915^87
+361 ;;^UTILITY(U,$J,358.3,22457,1,0)
+362 ;;=^358.31IA^4^2
+363 ;;^UTILITY(U,$J,358.3,22457,1,3,0)
+364 ;;=3^Personal Hx of Malig Neop of Lip,Oral Cavity & Pharynx,Unspec
+365 ;;^UTILITY(U,$J,358.3,22457,1,4,0)
+366 ;;=4^Z85.819
+367 ;;^UTILITY(U,$J,358.3,22457,2)
+368 ;;=^5063440
+369 ;;^UTILITY(U,$J,358.3,22458,0)
+370 ;;=Z85.01^^71^915^82
+371 ;;^UTILITY(U,$J,358.3,22458,1,0)
+372 ;;=^358.31IA^4^2
+373 ;;^UTILITY(U,$J,358.3,22458,1,3,0)
+374 ;;=3^Personal Hx of Malig Neop of Esophagus
+375 ;;^UTILITY(U,$J,358.3,22458,1,4,0)
+376 ;;=4^Z85.01
+377 ;;^UTILITY(U,$J,358.3,22458,2)
+378 ;;=^5063395
+379 ;;^UTILITY(U,$J,358.3,22459,0)
+380 ;;=Z85.028^^71^915^93
+381 ;;^UTILITY(U,$J,358.3,22459,1,0)
+382 ;;=^358.31IA^4^2
+383 ;;^UTILITY(U,$J,358.3,22459,1,3,0)
+384 ;;=3^Personal Hx of Malig Neop of Stomach
+385 ;;^UTILITY(U,$J,358.3,22459,1,4,0)
+386 ;;=4^Z85.028
+387 ;;^UTILITY(U,$J,358.3,22459,2)
+388 ;;=^5063397
+389 ;;^UTILITY(U,$J,358.3,22460,0)
+390 ;;=Z85.038^^71^915^84
+391 ;;^UTILITY(U,$J,358.3,22460,1,0)
+392 ;;=^358.31IA^4^2
+393 ;;^UTILITY(U,$J,358.3,22460,1,3,0)
+394 ;;=3^Personal Hx of Malig Neop of Large Intestine
+395 ;;^UTILITY(U,$J,358.3,22460,1,4,0)
+396 ;;=4^Z85.038
+397 ;;^UTILITY(U,$J,358.3,22460,2)
+398 ;;=^5063399
+399 ;;^UTILITY(U,$J,358.3,22461,0)
+400 ;;=Z85.048^^71^915^91
+401 ;;^UTILITY(U,$J,358.3,22461,1,0)
+402 ;;=^358.31IA^4^2
+403 ;;^UTILITY(U,$J,358.3,22461,1,3,0)
+404 ;;=3^Personal Hx of Malig Neop of Rectum,Rectosig Junct & Anus
+405 ;;^UTILITY(U,$J,358.3,22461,1,4,0)
+406 ;;=4^Z85.048
+407 ;;^UTILITY(U,$J,358.3,22461,2)
+408 ;;=^5063401
+409 ;;^UTILITY(U,$J,358.3,22462,0)
+410 ;;=Z85.118^^71^915^80
+411 ;;^UTILITY(U,$J,358.3,22462,1,0)
+412 ;;=^358.31IA^4^2
+413 ;;^UTILITY(U,$J,358.3,22462,1,3,0)
+414 ;;=3^Personal Hx of Malig Neop of Bronchus & Lung
+415 ;;^UTILITY(U,$J,358.3,22462,1,4,0)
+416 ;;=4^Z85.118
+417 ;;^UTILITY(U,$J,358.3,22462,2)
+418 ;;=^5063408
+419 ;;^UTILITY(U,$J,358.3,22463,0)
+420 ;;=Z85.21^^71^915^85
+421 ;;^UTILITY(U,$J,358.3,22463,1,0)
+422 ;;=^358.31IA^4^2
+423 ;;^UTILITY(U,$J,358.3,22463,1,3,0)
+424 ;;=3^Personal Hx of Malig Neop of Larynx
+425 ;;^UTILITY(U,$J,358.3,22463,1,4,0)
+426 ;;=4^Z85.21
+427 ;;^UTILITY(U,$J,358.3,22463,2)
+428 ;;=^5063411
+429 ;;^UTILITY(U,$J,358.3,22464,0)
+430 ;;=Z85.3^^71^915^79
+431 ;;^UTILITY(U,$J,358.3,22464,1,0)
+432 ;;=^358.31IA^4^2
+433 ;;^UTILITY(U,$J,358.3,22464,1,3,0)
+434 ;;=3^Personal Hx of Malig Neop of Breast
+435 ;;^UTILITY(U,$J,358.3,22464,1,4,0)
+436 ;;=4^Z85.3
+437 ;;^UTILITY(U,$J,358.3,22464,2)
+438 ;;=^5063416
+439 ;;^UTILITY(U,$J,358.3,22465,0)
+440 ;;=Z85.41^^71^915^81
+441 ;;^UTILITY(U,$J,358.3,22465,1,0)
+442 ;;=^358.31IA^4^2
+443 ;;^UTILITY(U,$J,358.3,22465,1,3,0)
+444 ;;=3^Personal Hx of Malig Neop of Cervix Uteri
+445 ;;^UTILITY(U,$J,358.3,22465,1,4,0)
+446 ;;=4^Z85.41
+447 ;;^UTILITY(U,$J,358.3,22465,2)
+448 ;;=^5063418
+449 ;;^UTILITY(U,$J,358.3,22466,0)
+450 ;;=Z85.43^^71^915^89
+451 ;;^UTILITY(U,$J,358.3,22466,1,0)
+452 ;;=^358.31IA^4^2
+453 ;;^UTILITY(U,$J,358.3,22466,1,3,0)
+454 ;;=3^Personal Hx of Malig Neop of Ovary
+455 ;;^UTILITY(U,$J,358.3,22466,1,4,0)
+456 ;;=4^Z85.43
+457 ;;^UTILITY(U,$J,358.3,22466,2)
+458 ;;=^5063420
+459 ;;^UTILITY(U,$J,358.3,22467,0)
+460 ;;=Z85.46^^71^915^90
+461 ;;^UTILITY(U,$J,358.3,22467,1,0)
+462 ;;=^358.31IA^4^2
+463 ;;^UTILITY(U,$J,358.3,22467,1,3,0)
+464 ;;=3^Personal Hx of Malig Neop of Prostate
+465 ;;^UTILITY(U,$J,358.3,22467,1,4,0)
+466 ;;=4^Z85.46
+467 ;;^UTILITY(U,$J,358.3,22467,2)
+468 ;;=^5063423
+469 ;;^UTILITY(U,$J,358.3,22468,0)
+470 ;;=Z85.47^^71^915^94
+471 ;;^UTILITY(U,$J,358.3,22468,1,0)
+472 ;;=^358.31IA^4^2
+473 ;;^UTILITY(U,$J,358.3,22468,1,3,0)
+474 ;;=3^Personal Hx of Malig Neop of Testis
+475 ;;^UTILITY(U,$J,358.3,22468,1,4,0)
+476 ;;=4^Z85.47
+477 ;;^UTILITY(U,$J,358.3,22468,2)
+478 ;;=^5063424
+479 ;;^UTILITY(U,$J,358.3,22469,0)
+480 ;;=Z85.51^^71^915^78
+481 ;;^UTILITY(U,$J,358.3,22469,1,0)
+482 ;;=^358.31IA^4^2
+483 ;;^UTILITY(U,$J,358.3,22469,1,3,0)
+484 ;;=3^Personal Hx of Malig Neop of Bladder
+485 ;;^UTILITY(U,$J,358.3,22469,1,4,0)
+486 ;;=4^Z85.51
+487 ;;^UTILITY(U,$J,358.3,22469,2)
+488 ;;=^5063428
+489 ;;^UTILITY(U,$J,358.3,22470,0)
+490 ;;=Z85.528^^71^915^83
+491 ;;^UTILITY(U,$J,358.3,22470,1,0)
+492 ;;=^358.31IA^4^2
+493 ;;^UTILITY(U,$J,358.3,22470,1,3,0)
+494 ;;=3^Personal Hx of Malig Neop of Kidney
+495 ;;^UTILITY(U,$J,358.3,22470,1,4,0)
+496 ;;=4^Z85.528
+497 ;;^UTILITY(U,$J,358.3,22470,2)
+498 ;;=^5063430
+499 ;;^UTILITY(U,$J,358.3,22471,0)
+500 ;;=Z85.6^^71^915^74
+501 ;;^UTILITY(U,$J,358.3,22471,1,0)
+502 ;;=^358.31IA^4^2
+503 ;;^UTILITY(U,$J,358.3,22471,1,3,0)
+504 ;;=3^Personal Hx of Leukemia
+505 ;;^UTILITY(U,$J,358.3,22471,1,4,0)
+506 ;;=4^Z85.6
+507 ;;^UTILITY(U,$J,358.3,22471,2)
+508 ;;=^5063434
+509 ;;^UTILITY(U,$J,358.3,22472,0)
+510 ;;=Z85.72^^71^915^98
+511 ;;^UTILITY(U,$J,358.3,22472,1,0)
+512 ;;=^358.31IA^4^2
+513 ;;^UTILITY(U,$J,358.3,22472,1,3,0)
+514 ;;=3^Personal Hx of Non-Hodgkin Lymphomas
+515 ;;^UTILITY(U,$J,358.3,22472,1,4,0)
+516 ;;=4^Z85.72
+517 ;;^UTILITY(U,$J,358.3,22472,2)
+518 ;;=^5063436
+519 ;;^UTILITY(U,$J,358.3,22473,0)
+520 ;;=Z85.79^^71^915^88
+521 ;;^UTILITY(U,$J,358.3,22473,1,0)
+522 ;;=^358.31IA^4^2
+523 ;;^UTILITY(U,$J,358.3,22473,1,3,0)
+524 ;;=3^Personal Hx of Malig Neop of Lymphoid,Hematpoetc & Rel Tissue
+525 ;;^UTILITY(U,$J,358.3,22473,1,4,0)
+526 ;;=4^Z85.79
+527 ;;^UTILITY(U,$J,358.3,22473,2)
+528 ;;=^5063437
+529 ;;^UTILITY(U,$J,358.3,22474,0)
+530 ;;=Z85.820^^71^915^77
+531 ;;^UTILITY(U,$J,358.3,22474,1,0)
+532 ;;=^358.31IA^4^2
+533 ;;^UTILITY(U,$J,358.3,22474,1,3,0)
+534 ;;=3^Personal Hx of Malig Melanoma of Skin
+535 ;;^UTILITY(U,$J,358.3,22474,1,4,0)
+536 ;;=4^Z85.820
+537 ;;^UTILITY(U,$J,358.3,22474,2)
+538 ;;=^5063441
+539 ;;^UTILITY(U,$J,358.3,22475,0)
+540 ;;=Z85.828^^71^915^92
+541 ;;^UTILITY(U,$J,358.3,22475,1,0)
+542 ;;=^358.31IA^4^2
+543 ;;^UTILITY(U,$J,358.3,22475,1,3,0)
+544 ;;=3^Personal Hx of Malig Neop of Skin
+545 ;;^UTILITY(U,$J,358.3,22475,1,4,0)
+546 ;;=4^Z85.828
+547 ;;^UTILITY(U,$J,358.3,22475,2)
+548 ;;=^5063443
+549 ;;^UTILITY(U,$J,358.3,22476,0)
+550 ;;=Z85.71^^71^915^72
+551 ;;^UTILITY(U,$J,358.3,22476,1,0)
+552 ;;=^358.31IA^4^2
+553 ;;^UTILITY(U,$J,358.3,22476,1,3,0)
+554 ;;=3^Personal Hx of Hodgkin Lymphoma
+555 ;;^UTILITY(U,$J,358.3,22476,1,4,0)
+556 ;;=4^Z85.71
+557 ;;^UTILITY(U,$J,358.3,22476,2)
+558 ;;=^5063435
+559 ;;^UTILITY(U,$J,358.3,22477,0)
+560 ;;=Z65.8^^71^915^144
+561 ;;^UTILITY(U,$J,358.3,22477,1,0)
+562 ;;=^358.31IA^4^2
+563 ;;^UTILITY(U,$J,358.3,22477,1,3,0)
+564 ;;=3^Psychosocial Circumstance Related Problems
+565 ;;^UTILITY(U,$J,358.3,22477,1,4,0)
+566 ;;=4^Z65.8
+567 ;;^UTILITY(U,$J,358.3,22477,2)
+568 ;;=^5063185
+569 ;;^UTILITY(U,$J,358.3,22478,0)
+570 ;;=Z86.11^^71^915^109
+571 ;;^UTILITY(U,$J,358.3,22478,1,0)
+572 ;;=^358.31IA^4^2
+573 ;;^UTILITY(U,$J,358.3,22478,1,3,0)
+574 ;;=3^Personal Hx of Tuberculosis
+575 ;;^UTILITY(U,$J,358.3,22478,1,4,0)
+576 ;;=4^Z86.11
+577 ;;^UTILITY(U,$J,358.3,22478,2)
+578 ;;=^5063461
+579 ;;^UTILITY(U,$J,358.3,22479,0)
+580 ;;=Z86.13^^71^915^76
+581 ;;^UTILITY(U,$J,358.3,22479,1,0)
+582 ;;=^358.31IA^4^2
+583 ;;^UTILITY(U,$J,358.3,22479,1,3,0)
+584 ;;=3^Personal Hx of Malaria
+585 ;;^UTILITY(U,$J,358.3,22479,1,4,0)
+586 ;;=4^Z86.13
+587 ;;^UTILITY(U,$J,358.3,22479,2)
+588 ;;=^5063463
+589 ;;^UTILITY(U,$J,358.3,22480,0)
+590 ;;=Z86.73^^71^915^106
+591 ;;^UTILITY(U,$J,358.3,22480,1,0)
+592 ;;=^358.31IA^4^2
+593 ;;^UTILITY(U,$J,358.3,22480,1,3,0)
+594 ;;=3^Personal Hx of TIA & Cereb Infrc w/o Residual Deficits
+595 ;;^UTILITY(U,$J,358.3,22480,1,4,0)
+596 ;;=4^Z86.73
+597 ;;^UTILITY(U,$J,358.3,22480,2)
+598 ;;=^5063477
+599 ;;^UTILITY(U,$J,358.3,22481,0)
+600 ;;=Z86.79^^71^915^69
+601 ;;^UTILITY(U,$J,358.3,22481,1,0)
+602 ;;=^358.31IA^4^2
+603 ;;^UTILITY(U,$J,358.3,22481,1,3,0)
+604 ;;=3^Personal Hx of Circulatory System Diseases
+605 ;;^UTILITY(U,$J,358.3,22481,1,4,0)
+606 ;;=4^Z86.79
+607 ;;^UTILITY(U,$J,358.3,22481,2)
+608 ;;=^5063479
+609 ;;^UTILITY(U,$J,358.3,22482,0)
+610 ;;=Z91.040^^71^915^57
+611 ;;^UTILITY(U,$J,358.3,22482,1,0)
+612 ;;=^358.31IA^4^2
+613 ;;^UTILITY(U,$J,358.3,22482,1,3,0)
+614 ;;=3^Latex Allergy Status
+615 ;;^UTILITY(U,$J,358.3,22482,1,4,0)
+616 ;;=4^Z91.040
+617 ;;^UTILITY(U,$J,358.3,22482,2)
+618 ;;=^5063607
+619 ;;^UTILITY(U,$J,358.3,22483,0)
+620 ;;=Z92.3^^71^915^73
+621 ;;^UTILITY(U,$J,358.3,22483,1,0)
+622 ;;=^358.31IA^4^2
+623 ;;^UTILITY(U,$J,358.3,22483,1,3,0)
+624 ;;=3^Personal Hx of Irradiation
+625 ;;^UTILITY(U,$J,358.3,22483,1,4,0)
+626 ;;=4^Z92.3
+627 ;;^UTILITY(U,$J,358.3,22483,2)
+628 ;;=^5063637
+629 ;;^UTILITY(U,$J,358.3,22484,0)
+630 ;;=Z91.120^^71^915^53
+631 ;;^UTILITY(U,$J,358.3,22484,1,0)
+632 ;;=^358.31IA^4^2
+633 ;;^UTILITY(U,$J,358.3,22484,1,3,0)
+634 ;;=3^Intentional Underdose of Meds d/t Financial Hardship
+635 ;;^UTILITY(U,$J,358.3,22484,1,4,0)
+636 ;;=4^Z91.120
+637 ;;^UTILITY(U,$J,358.3,22484,2)
+638 ;;=^5063612
+639 ;;^UTILITY(U,$J,358.3,22485,0)
+640 ;;=Z91.11^^71^915^62
+641 ;;^UTILITY(U,$J,358.3,22485,1,0)
+642 ;;=^358.31IA^4^2
+643 ;;^UTILITY(U,$J,358.3,22485,1,3,0)
+644 ;;=3^Noncompliance w/ Dietary Regimen
+645 ;;^UTILITY(U,$J,358.3,22485,1,4,0)
+646 ;;=4^Z91.11
+647 ;;^UTILITY(U,$J,358.3,22485,2)
+648 ;;=^5063611
+649 ;;^UTILITY(U,$J,358.3,22486,0)
+650 ;;=Z87.891^^71^915^97
+651 ;;^UTILITY(U,$J,358.3,22486,1,0)
+652 ;;=^358.31IA^4^2
+653 ;;^UTILITY(U,$J,358.3,22486,1,3,0)
+654 ;;=3^Personal Hx of Nicotine Dependence
+655 ;;^UTILITY(U,$J,358.3,22486,1,4,0)
+656 ;;=4^Z87.891
+657 ;;^UTILITY(U,$J,358.3,22486,2)
+658 ;;=^5063518
+659 ;;^UTILITY(U,$J,358.3,22487,0)
+660 ;;=Z77.090^^71^915^3
+661 ;;^UTILITY(U,$J,358.3,22487,1,0)
+662 ;;=^358.31IA^4^2
+663 ;;^UTILITY(U,$J,358.3,22487,1,3,0)
+664 ;;=3^Asbestos Contact/Exposure
+665 ;;^UTILITY(U,$J,358.3,22487,1,4,0)
+666 ;;=4^Z77.090
+667 ;;^UTILITY(U,$J,358.3,22487,2)
+668 ;;=^5063312
+669 ;;^UTILITY(U,$J,358.3,22488,0)
+670 ;;=Z57.8^^71^915^65
+671 ;;^UTILITY(U,$J,358.3,22488,1,0)
+672 ;;=^358.31IA^4^2
+673 ;;^UTILITY(U,$J,358.3,22488,1,3,0)
+674 ;;=3^Occupational Exposure to Other Risk Factors
